An Outbreak of Oropharyngeal Tularemia with Cervical Adenopathy Predominantly in the Left Side
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: We describe the epidemiological and clinical characteristics and the efficacy of a delayed initiation to therapy in an oropharyngeal tularemia outbreak in Duzce, Turkey. Materials and Methods: Between March and June 2000, 22 patients with tularemia were diagnosed by microagglutination tests. Results: Oropharyngeal and ulceroglandular forms of the disease were discovered. Most of the cases were oropharyngeal (19 cases). The most common symptoms were sore throat (95.4%) and fever (90.9%). Lymphadenopathy (95.4%) and pharyngeal hyperemia (81.8%) were usually observed signs. The lymphadenopathies were localized especially in the left cervical region (66.7%), a finding that has not been previously reported in the literature. The time between the onset of the symptoms and diagnosis was 40.7±22.8 (10-90) days. The patients were treated with streptomycin plus doxycycline and ciprofloxacin. The patients' recoveries took up to 120 days. Conclusion: This report describes the first outbreak of tularemia in northwest Turkey. Tularemia may occur in any region where appropriate epidemiological conditions are found and should be kept in mind for differential diagnosis in oropharyngeal symptoms. Late initiation of therapy may delay complete recovery. In this outbreak, cervical lymph nodes predominantly localized on the 1eft side were found, which had not been previously reported.
Abstract
Purpose: We describe the epidemiological and clinical characteristics and the efficacy of a delayed initiation to therapy in an oropharyngeal tularemia outbreak in Duzce, Turkey. Materials and Methods: Between March and June 2000, 22 patients with tularemia were diagnosed by microagglutination tests. Results: Oropharyngeal and ulceroglandular forms of the disease were discovered. Most of the cases were oropharyngeal (19 cases). The most common symptoms were sore throat (95.4%) and fever (90.9%). Lymphadenopathy (95.4%) and pharyngeal hyperemia (81.8%) were usually observed signs. The lymphadenopathies were localized especially in the left cervical region (66.7%), a finding that has not been previously reported in the literature. The time between the onset of the symptoms and diagnosis was 40.7±22.8 (10-90) days. The patients were treated with streptomycin plus doxycycline and ciprofloxacin. The patients' recoveries took up to 120 days. Conclusion: This report describes the first outbreak of tularemia in northwest Turkey. Tularemia may occur in any region where appropriate epidemiological conditions are found and should be kept in mind for differential diagnosis in oropharyngeal symptoms. Late initiation of therapy may delay complete recovery. In this outbreak, cervical lymph nodes predominantly localized on the 1eft side were found, which had not been previously reported.
참고문헌 (19)
- Jacobs RF, "Tularemia, in Harrison's principles of internal medicine", pp.971~975 (1998), McGraw-Hill
- Maranan MC, "Pneumonic tularemia in a patient with chronic granulomatous disease", Clin Infect Dis, 25, pp.630~633 (1997)
- Byrd RP Jr, "Respiratory manifestation of tick-borne diseases in the Southeastern United States", South Med J, 90, pp.1~4 (1997)
- Berdal BP, "Field detection of Francisella tularensis", Scand J Infect Dis, 32, pp.287~291 (2000)
- Reintjes R, "Tularemia outbreak investigation in Kosovo: case control and environmental studies", Emerg Infect Dis, 8, pp.69~73 (2002)
- Tärnvik A, "Infrequent manifestations of tularaemia in Sweden", Scand J Infect Dis, 29, pp.443~446 (1997)
- Penn RL, "Francisella tularensis (Tularemia), in Mandell, Douglas and Bennett's principles and practice of infectious diseases. 4th ed", pp.2060~2068 (1995), Churchill Ligingstone
- Syrjälä H, "Airborne transmission of tularemia in farmers", Scand J Infect Dis, 17, pp.371~375 (1985)
- de la Puente-Redondo VA, "Comparison of different PCR approaches for typing of Francisella tularensis strains", J Clin Microbiol, 38, pp.1016~1622 (2000)
- Sato T, "Microagglutination test for early specific serodiagnosis of tularemia", J Clin Microbiol, 28, pp.2372~2374 (1990)
- Enderlin G, "Streptomycin and alternative agents for the treatment of tularemia: review of the literature", Clin Infect Dis, 19, pp.42~47 (1994)
- Baker CN, "Antimicrobial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth", J Clin Microbiol, 22, pp.212~215 (1985)
- Akdiş AC, "Immunological evaluation of erythema nodosum in tularaemia", Br J Dermatol, 129, pp.275~279 (1993)
- Pérez-Castrillón JL, "Tularemia epidemic in northwestern Spain: clinical description and therapeutic response", Clin Infect Dis, 33, pp.573~576 (2001)
- Taylor JP, "Epidemiologic characteristics of human tularemia in the southwest-central states, 1981-1987", Am J Epidemiol, 133, pp.1032~1038 (1999)
- Christenson B, "An outbreak of tularemia in the northern part of central Sweden", Scand J Infect Dis, 16, pp.285~290 (1984)
- Helvaci S, "Tularemia in Bursa, Turkey: 205 cases in ten years", Eur J Epidemiol, 16, pp.271~276 (2000)
- Ohara Y, "Clinical manifestations of tularemia in Japan-analysis of 1,355 cases observed between 1924 and 1987", Infection, 19, pp.14~17 (1991)
- Syrjälä H, "In vitro susceptibility of Francisella tularensis to fluoroquinolones and treatment of tularemia with norfloxacin and ciprofloxacin", Eur J Clin Microbiol Infect Dis, 10, pp.68~70 (1991)